Matches in Nanopublications for { ?s ?p ?o <http://rdf.disgenet.org/nanopublications.trig#NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance>. }
Showing items 1 to 9 of
9
with 100 items per page.
- source_evidence_literature type ECO_0000212 NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance.
- source_evidence_literature label "DisGeNET evidence - LITERATURE" NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance.
- source_evidence_literature comment "Gene-disease associations inferred from text-mining the literature." NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance.
- NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_assertion description "[Treatment of progression of Philadelphia-negative myeloproliferative neoplasms to myelodysplastic syndrome or acute myeloid leukemia by azacitidine: a report on 54 cases on the behalf of the Groupe Francophone des Myelodysplasies (GFM).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance.
- NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_assertion evidence source_evidence_literature NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance.
- NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_assertion SIO_000772 20664061 NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance.
- NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_assertion wasDerivedFrom befree-20140225 NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance.
- NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_assertion wasGeneratedBy ECO_0000203 NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance.
- befree-20140225 importedOn "2014-02-25" NP220693.RAjuT9shB8Yx_OZs1gUQpxgmEeRMC5VFpX4NTCPuPoWBg130_provenance.